全球基于人工智能的磁共振成像 (MRI) 市场 – 2029 年行业趋势和预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球基于人工智能的磁共振成像 (MRI) 市场 – 2029 年行业趋势和预测

  • Medical Devices
  • Upcoming Report
  • Jul 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Artificial Intelligence Based Mri Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 4.80 Billion
Diagram Market Size (Forecast Year)
USD 8.12 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>全球人工智能 - 基于磁共振成像 (MRI) 市场,按解决方案(硬件、软件、服务)、技术(语音识别、查询方法、自然语言处理、机器学习、上下文感知处理)、最终用户(医院、制药组织、诊断中心、诊所)、部署类型(本地、云)、临床应用(乳腺、肺、神经内科、心血管、肝脏、前列腺、结肠、肌肉骨骼等)划分 - 行业趋势和预测至 2029 年

基于人工智能的磁共振成像(MRI)市场

市场分析和规模

预计全球基于人工智能的磁共振成像 (MRI) 市场将在预测期内出现显着增长。研究人员正在探索在医学图像中实现人工智能的多种方法。医学成像软件市场对人工智能的需求正在稳步增长。人工智能,例如心脏事件、神经系统疾病、骨折和胸部并发症,可帮助医生快速诊断和治疗。人工智能在医学图像中的应用使得改善医疗筛查、改进精准医疗软件和减轻医生负担成为可能。COVID-19 的影响极大地影响了基于人工智能的磁共振成像 (MRI) 市场。

Data Bridge Market Research 分析了 2022-2029 年预测期内基于人工智能的磁共振成像 (MRI) 市场的增长率。在上述预测期内,基于人工智能的磁共振成像 (MRI) 市场的预期复合年增长率趋于 6.80% 左右。2021 年市场价值为 48 亿美元,到 2029 年将增长至 81.2 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

市场定义

人工智能 (AI) 是计算机科学的一个分支,旨在通过图像分析和语音识别等智能系统模拟人类智能。医学成像是一种技术和过程,用于对身体进行成像以进行临床分析和医疗程序,以及可视化某些器官和组织的功能。人工智能方法的特点是自动识别复杂的图像数据模式并定量而非定性地评估 X 射线照片的特征。

报告范围和市场细分

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制为 2014 - 2019)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

By Solution (Hardware, Software, Services), Technology (Speech Recognition, Querying Method, Natural Language Processing, Machine Learning, Context Aware Processing), End User (Hospitals, Pharmaceutical Organizations, Diagnostic Centers, Clinics), Deployment Type (On-Premise, Cloud), Clinical Application (Breast, Lung, Neurology, Cardiovascular, Liver, Prostate, Colon, Musculoskeletal, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

NVIDIA Corporation (U.S.), OrCam (Israel), Freenome Holdings Inc. (U.S.), Clarify Health Solutions (U.S.), BioXcel Therapeutics (U.S.), GNS Healthcare (U.S.)., Qventus (U.S.)., K Health Inc. (U.S.), Huma (U.S.)., Voxel (Kuwait), Renalytix (U.S.), mPulse Mobile (U.S.), Suki AI Inc. (China), BERG LLC (U.S.), OWKIN INC. (U.S), and Your.MD (U.K.)

Market Opportunities

  • Rising Shift of Doctors on AI based techniques
  • Emerging Economies

Global Artificial Intelligence - Based Magnetic Resonance Imaging (MRI) Market Dynamics

Drivers

  • Rising Demand of AI in COVID-19 Related Issues

As the number of cases of COVID-19 surges around the world, new AI technologies are being developed to help hospitals expand their second-wave treatment. The COVID-19 pandemic has increased corporate image processing and telemedicine demand through remote access to images and reports. It also emphasizes the importance of expanding the use of AI and machine learning in diagnostic imaging, with two goals: improving diagnostics and improving clinician well-being and employment safety. Scientists have made significant additions to the campaign to fight COVID-19. Research results, such as analytical reports and publications, reported by both industrial and academic researchers are increasing daily.

  • Economic Friendly and Accurate Precision

In recent years, AI has shown incredible accuracy and sensitivity in the classification of image anomalies, improving tissue-based detection and characterization. Incorporating AI into healthcare and medical imaging has changed the nature of diagnostics and contributed to the growth of the global AI medical imaging market. Artificial intelligence helps doctors perform imaging procedures and helps diagnose these images for diagnosis and individualized treatment of each patient. Researchers apply AI to automatically recognize complex patterns of image data and quantitatively evaluate the characteristics of radiographs.

Opportunities

  • Rising Shift of Doctors on AI based techniques

Several major AI players in the medical imaging market are beginning to partner with or collaborate with leading AI technology providers to develop AI-based solutions for healthcare applications. With such an approach, these market participants can provide consumers with advanced solutions and establish their position in this dynamic market environment. As the demand for AI-based technologies grows, advances can give enterprises momentum in the development of advanced products and tools. However, there are some areas where AI technology is expected to have a significant impact. These include improved diagnostics and accidental discoveries from images, predictive image analysis, workflow efficiency with data analysis, and reporting and prioritization of critical discoveries.

  • Emerging Economies

Developing nations are focusing on accelerating their AI stakes, which will help companies integrate AI with medical imaging to enhance their revenue share. For instance, China is aiming to be the global leader in AI by the year 2030. The strategy involves large government funding and investments to upsurge the adoption of AI solutions in companies. Moreover, the rising patient population in countries such as India, China, and Brazil is expected to have meaningful growth opportunities for players operating in the AI based MRI market.

Restraints/Challenges

  • Lack of skilled professionals

The lack of qualified personnel who are unable to use these techniques could curb the growth of the artificial intelligence - based magnetic resonance imaging (MRI) market over a forecast period.

  • High Cost

The huge expenditure required to set up or develop the techniques will hamper market growth. Several market players make huge investment in installing new and advanced machines to faster the process and in return the cost is increased.

This artificial intelligence - based magnetic resonance imaging (MRI) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the artificial intelligence - based magnetic resonance imaging (MRI) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Artificial Intelligence - Based Magnetic Resonance Imaging (MRI) Market

从目前的情况来看,COVID-19 已造成前所未有的全球公共卫生危机,几乎影响到所有企业。其长期影响预计将在预测期内影响行业增长。

人工智能 (AI) 在医学磁共振成像中越来越受欢迎,用于检测和预测疾病。与传统的图像处理方法相比,基于 AI 的图像分析算法提供了更可靠、高效、快速、稳定和可重复的疾病信息。因此,图像分析、受感染肺部区域的图像分割和临床评估分析是基于 AI 的 COVID-19 诊断方法的基础。这些基于 AI 的方法展示了 AI 在预测区间内医学成像市场商业化的潜力。

全球基于人工智能的磁共振成像 (MRI) 市场范围

基于人工智能的磁共振成像 (MRI) 市场根据解决方案、技术、最终用户、部署类型和临床应用进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

解决方案

  • 硬件
  • 软件
  • 服务

技术

  • 语音识别
  • 查询方式
  • 自然语言处理
  • 机器学习
  • 情境感知处理

最终用户

  • 医院
  • 制药组织
  • 诊断中心
  • 诊所

部署类型

  • 本地部署

临床应用

  • 胸部
  • 神经病学
  • 心血管
  • 前列腺
  • 冒号
  • 肌肉骨骼
  • 其他的

基于人工智能的磁共振成像 (MRI) 市场区域分析/见解

对基于人工智能的磁共振成像 (MRI) 市场进行了分析,并按上述解决方案、技术、最终用户、部署类型和临床应用提供了市场规模洞察和趋势。

人工智能磁共振成像(MRI)市场的主要国家包括北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区(APAC)的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区(APAC)的其他地区、中东和非洲(MEA)的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于医疗诊断中医疗 IT 解决方案的采用率不断提高、医疗保健行业成熟度高以及对基于 AI 的诊断软件开发的资金充足,北美在基于人工智能的磁共振成像 (MRI) 市场中占据主导地位。由于政府出台越来越多的鼓励医疗保健提供商的举措,亚太地区有望成为基于人工智能的 MRI 市场增长的地区。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外,在提供国家数据预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和全球基于人工智能的磁共振成像(MRI)市场份额分析

基于人工智能的磁共振成像 (MRI) 市场竞争格局提供了按竞争对手划分的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对基于人工智能的磁共振成像 (MRI) 市场的关注有关。

基于人工智能的磁共振成像(MRI)市场的主要参与者包括:

  • NVIDIA 公司(美国)
  • OrCam(以色列)
  • Freenome Holdings Inc.(美国)
  • Clarify Health Solutions(美国)
  • BioXcel Therapeutics(美国)
  • GNS Healthcare(美国)
  • Qventus(美国)
  • K Health Inc.(美国)
  • Huma(美国)
  • Voxel(科威特)
  • Renalytix(美国)
  • mPulse 移动版(美国)
  • Suki AI Inc.(中国)
  • BERG LLC(美国)
  • OWKIN INC.(美国)
  • Your.MD(英国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The artificial intelligence - based magnetic resonance imaging (MRI) market is projected to grow at a CAGR of 6.80% during the forecast period of 2022-2029.
The Artificial Intelligence - Based Magnetic Resonance Imaging (MRI) Market value is expected USD 8.12 billion by 2029.
On the basis of technology, the Artificial Intelligence - Based Magnetic Resonance Imaging (MRI) Market is segmented into Speech Recognition, Querying Method, Natural Language Processing, Machine Learning, Context Aware Processing.
The major players operating in the Artificial Intelligence - Based Magnetic Resonance Imaging (MRI) Market are NVIDIA Corporation (U.S.), OrCam (Israel), Freenome Holdings Inc. (U.S.), Clarify Health Solutions (U.S.), BioXcel Therapeutics (U.S.), GNS Healthcare (U.S.)., Qventus (U.S.)., K Health Inc. (U.S.), Huma (U.S.)., Voxel (Kuwait), Renalytix (U.S.), mPulse Mobile (U.S.), Suki AI Inc. (China), BERG LLC (U.S.), OWKIN INC. (U.S), and Your.MD (U.K.).